Brent Saunders out as Bausch + Lomb CEO, abrupt end to three-year run
Brent Saunders, one of biopharma’s most prominent dealmakers and highest-paid leaders, is out as CEO of Bausch + Lomb, failing to add another multibillion-dollar company sale to his resume. In a
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.